Key result
This review analyzes current clinical practice guidelines from four major endoscopy organizations to provide general recommendations on managing antithrombotic agents during elective gastrointestinal endoscopy.
Why the study?
Managing antithrombotic therapy in patients undergoing endoscopic procedures presents a clinical challenge in balancing thromboembolic and bleeding risks.
How should antithrombotic agents be managed in patients undergoing elective gastrointestinal endoscopy to balance bleeding and thromboembolic risks?
How should antithrombotic agents be managed in patients undergoing elective gastrointestinal endoscopy to balance bleeding and thromboembolic risks?
This review synthesizes guidelines from four major endoscopy organizations to guide the management of antithrombotic agents during elective gastrointestinal endoscopy.
Provides consolidated guideline recommendations for antithrombotic management in endoscopy; leaves open the need for outcome validation.
Antithrombotic agents, including antiplatelet agents and anticoagulants, are increasingly used in South Korea. Antithrombotic agents reduce the risk of thromboembolism; however, they increase the risk of bleeding. The management of patients on antithrombotic agents, who are also undergoing endoscopic procedures, has become a common and significant clinical challenge. Decisions regarding the management of antithrombotic agents prior to endoscopic procedures should be made with a comprehensive consideration of the risk of thromboembolism related to the discontinuation of antithrombotic agents, along with the risk of bleeding associated with the endoscopic procedures. Four major endoscopy organizations (American Society of Gastrointestinal Endoscopy, Asian Pacific Association of Gastroenterology/Asian Pacific Society for Digestive Endoscopy, British Society of Gastroenterology/European Society of Gastrointestinal Endoscopy, and Japan Gastroenterological Endoscopy Society) have put-forth clinical practice guidelines to assist gastroenterologists in making decisions regarding the appropriate choice of treatments pertaining to the use of antithrombotic agents before and after endoscopic procedures. This review aimed to analyze the current clinical practice guidelines and provide general recommendations on the management of antithrombotic agents in patients undergoing elective gastrointestinal endoscopy.
No takes yet. Share an insight, caveat, or question.
Hyun Lim (2020) conducted a review in Patients on antithrombotic agents undergoing elective gastrointestinal endoscopy. Management of antithrombotic agents was evaluated. This review analyzes current clinical practice guidelines from four major endoscopy organizations to provide general recommendations on managing antithrombotic agents during elective gastrointestinal endoscopy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: